<DOC>
	<DOCNO>NCT02609685</DOCNO>
	<brief_summary>The purpose study well understand outcomes active surveillance ( observation ) instead immediate surgery , current standard care papillary thyroid microcarcinoma ( PTMC ) . Patients 1.5 cm small thyroid nodule ( ) papillary thyroid carcinoma eligible study .</brief_summary>
	<brief_title>Active Surveillance Papillary Thyroid Microcarcinoma</brief_title>
	<detailed_description>The incidence thyroid cancer double last 30 year United States , Europe , Canada , South America . Since nearly 50 % increase attributable papillary thyroid microcarcinomas ( PTMC ) , appear great detection diagnosis previously subclinical disease major factor drive dramatic rise . The primary objective estimate rate disease progression ( growth primary tumor development loco-regional/distant metastasis ) 3 , 5 , 10-year period series PTMC patient follow active surveillance United States . Patients opt immediate surgery participate sub-study look quality life anxiety measure compare patient enroll active surveillance main study . Patients enroll active surveillance choose surgery time treat physician feel best interest .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Carcinoma , Papillary</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>Pathologically confirm Bethesda V VI thyroid nodule papillary thyroid carcinoma 1.5 cm small nodule ultrasonographic criterion Ability understand willingness sign write informed consent HIPAA Authorization form Highgrade poorly differentiate PTC variant Central lateral neck lymphadenopathy suspicious PTC Unfavorable nodule location ( e.g . Near dorsal surface ( recurrent laryngeal nerve ) ; Adjacent trachea ( risk cartilage invasion ) History radiation neck</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Thyroid cancer</keyword>
	<keyword>Active surveillance</keyword>
	<keyword>PTMC</keyword>
</DOC>